GC-MS-based urine metabolic profiling of autism spectrum disorders.

Emond, Patrick; Mavel, Sylvie; Aïdoud, Nacima; Nadal-Desbarats, Lydie; Montigny, Frédéric; Bonnet-Brilhault, Frédérique; Barthélémy, Catherine; Merten, Marc; Sarda, Pierre; Laumonnier, Frédéric; Vourc'h, Patrick; Blasco, Hélène; Andres, Christian R

Emond, Patrick; Mavel, Sylvie; Aïdoud, Nacima; Nadal-Desbarats, Lydie; Montigny, Frédéric; Bonnet-Brilhault, Frédérique; Barthélémy, Catherine; Merten, Marc; Sarda, Pierre; Laumonnier, Frédéric; Vourc'h, Patrick; Blasco, Hélène; Andres, Christian R.

Affiliation

Emond P; INSERM U930, Equipe neurogénétique et neurométabolomique, CHRU de Tours, Hôpital Bretonneau, Université François-Rabelais, 10 Bv Tonnellé, 37044 Tours, France. patrick.emond@univ-tours.fr

Anal Bioanal Chem ; 405(15): 5291-300, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23571465

Subject(s)

Child Development Disorders, Pervasive/urine; Metabolomics/methods; Adolescent; Case-Control Studies; Chemical Fractionation; Child; Female; Gas Chromatography-Mass Spectrometry/methods; Humans; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Child Development Disorders, Pervasive / Metabolomics Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google